Alnylam Pharmaceuticals, Inc. (ALNY)
320.60
-4.46
(-1.37%)
USD |
NASDAQ |
Mar 03, 15:40
Alnylam Pharmaceuticals Research and Development Expense (Annual) : 1.320B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insmed, Inc. | 771.09M |
| Biogen, Inc. | 1.481B |
| Pfizer Inc. | 10.25B |
| Eli Lilly & Co. | 13.34B |
| AbbVie, Inc. | 8.249B |